Dishman signs agreement with Polpharma SA of Poland
Dishman signs agreement with Polpharma SA of Poland
Mumbai: Mumbai-based drug ingredients manufacturer Dishman Pharmaceuticals and Chemicals Ltd has said that it has signed joint development product agreement with Polpharma SA of Poland.
Polpharma is key player in its home market and a leader in the central and eastern European markets and also CIS countries with a turnover of $400 million. It is also a leader in the active pharma ingredient (API) sales with almost 90% of which in regulated markets including the US. The Dishman group, a dedicated contract manufacturer has a $200 million sales.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!